| Literature DB >> 35046772 |
Amina Becic1, Jennifer Leifeld1, Javeria Shaukat1, Michael Hollmann1.
Abstract
Tetraspanins (Tspans) comprise a membrane protein family structurally defined by four transmembrane domains and intracellular N and C termini that is found in almost all cell types and tissues of eukaryotes. Moreover, they are involved in a bewildering multitude of diverse biological processes such as cell adhesion, motility, protein trafficking, signaling, proliferation, and regulation of the immune system. Beside their physiological roles, they are linked to many pathophysiological phenomena, including tumor progression regulation, HIV-1 replication, diabetes, and hepatitis. Tetraspanins are involved in the formation of extensive protein networks, through interactions not only with themselves but also with numerous other specific proteins, including regulatory proteins in the central nervous system (CNS). Interestingly, recent studies showed that Tspan7 impacts dendritic spine formation, glutamatergic synaptic transmission and plasticity, and that Tspan6 is correlated with epilepsy and intellectual disability (formerly known as mental retardation), highlighting the importance of particular tetraspanins and their involvement in critical processes in the CNS. In this review, we summarize the current knowledge of tetraspanin functions in the brain, with a particular focus on their impact on glutamatergic neurotransmission. In addition, we compare available resolved structures of tetraspanin family members to those of auxiliary proteins of glutamate receptors that are known for their modulatory effects.Entities:
Keywords: CNS; glutamate receptor; modulator structures; synaptic function; tetraspanins
Year: 2022 PMID: 35046772 PMCID: PMC8761850 DOI: 10.3389/fnmol.2021.801882
Source DB: PubMed Journal: Front Mol Neurosci ISSN: 1662-5099 Impact factor: 5.639
Summary of human tetraspanins with their alternative names, tissue specificity and the functions.
| Name | Alternative names | Tissue specificity | Protein function |
| Tetraspanin1 | TSPAN-1, NET-1 | Intestine, testis | Regulation of cell development, activation, growth and motility ( |
| Tetraspanin2 | TSPAN-2, FLJ12082, TSN2 | Smooth muscle | Contribution to oligodendrocyte differentiation into myelin-forming glia ( |
| Tetraspanin3 | TSPAN-3, TM4-A, TM4SF8 | Low tissue specificity | Regulation of the expression of ADAM10, presenilin and the amyloid precursor protein ( |
| Tetraspanin4 | TSPAN-4, NAG-2, TM4SF7 | Low tissue specificity | Potential biomarker in hepatocellular carcinoma and plays a critical role in promoting cancer cell proliferation ( |
| Tetraspanin5 | TSPAN-5, NET-4, TM4SF9 | Brain and ovary | Promotes metastasis of hepatocellular carcinoma through Notch signaling ( |
| Tetraspanin6 | TSPAN-6, T245, TM4SF6 | Salivary gland | Regulator of carcinogenesis in colorectal cancer ( |
| Tetraspanin7 | TSPAN-7, A15, CD231, DXS1692E, MRX58, MXS1, TALLA-1, TM4SF2 | Brain | Involved in HIV-1 host-virus interaction ( |
| Tetraspanin8 | TSPAN-8, CO-029, TM4SF3 | Intestine | Target candidate for immunotherapy of pancreatic adenocarcinoma ( |
| Tetraspanin9 | TSPAN9, NET-5 | Brain, heart muscle | Regulates gastric cancer cell migration and invasion ( |
| Tetraspanin10 | TSPAN10, OCSP | Retina | Involved in trafficking regulation of the transmembrane metalloprotease ADAM10 ( |
| Tetraspanin11 | TSPAN11 | Intestine | Participates in determining the direction of bone matrix organization ( |
| Tetraspanin12 | TSPAN12, NET-2, TM4SF12 | Low tissue specificity | Involved in retinal vascularization by regulating norrin (NDP) signal transduction ( |
| Tetraspanin13 | TSPAN13, NET-6, TM4SF13 | Low tissue specificity | Potential marker indicating the outcome of breast cancer ( |
| Tetraspanin14 | TSPAN14, DC-TM4F2, MGC11352, TM4SF14 | Low tissue specificity | Regulates maturation and trafficking of the transmembrane metalloprotease ADAM10 ( |
| Tetraspanin15 | TSPAN15, NET-7, TM4SF15 | Low tissue specificity | Essential subunit of an ADAM10 scissor complex ( |
| Tetraspanin16 | TSPAN16, TM-8, TM4-B, TM4SF16 | Blood, testis | Under-expressed in acute lymphoblastic leukemia ( |
| Tetraspanin17 | TSPAN17, FBX23, FBXO23, TM4SF17 | Low tissue specificity | Involved in regulation of ADAM10 trafficking ( |
| Tetraspanin18 | TSPAN18 | Low tissue specificity | Regulator of thrombo-inflamation ( |
| Tetraspanin19 | TSPAN19 | Lung, pituitary gland | Specific function unclear |
| Tetraspanin20 | TSPAN20, UPK1B, UPK1, Uroplakin 1B | Placenta, urinary bladder | Plays an important role in normal bladder epithelial physiology ( |
| Tetraspanin21 | TSPAN21, UPK1A, Uroplakin 1A | Prostate, urinary bladder | Plays an important role in normal bladder epithelial physiology ( |
| Tetraspanin22 | TSPAN22, PRPH2, CACD2, rd2, RDS, RP7, Peripherin 2 | Retina | Essential for retina photoreceptor outer segment disk morphogenesis ( |
| Tetraspanin23 | TSPAN23, ROM1, ROM, Retinal outer segment membrane protein 1 | Retina | Plays a role in rod outer segment (ROS) morphogenesis ( |
| Tetraspanin24 | TSPAN24, CD151 molecule (Raph blood group), CD151 (PETA-3, RAPH, SFA-1 | Low tissue specificity | Essential in kidney and skin morphogenesis ( |
| Tetraspanin25 | TSPAN25, CD53, MOX44 | Blood, lymphoid tissue | Immune cell function regulator ( |
| Tetraspanin26 | TSPAN26, CD37 | Blood, lymphoid tissue | Potential biomarker in acute myeloid leukemia ( |
| Tetraspanin27 | TSPAN27, CD82, IA4, KAI1, R2, ST6 | Low tissue specificity | Suppresses migration in prostate cancer ( |
| Tetraspanin28 | TSPAN28, CD81, TAPA-1, TAPA1 | Low tissue specificity | Involved in lymphocyte cell membrane organization ( |
| Tetraspanin29 | TSPAN29, CD9, BA2, MIC3, MRP-1, P24 | Low tissue specificity | Regulates development of acute myeloid leukemia ( |
| Tetraspanin30 | TSPAN30, CD63, ME491, MLA1 | Low tissue specificity | Negatively regulates hepatocellular carcinoma ( |
| Tetraspanin31 | TSPAN31, SAS | Low tissue specificity | Suppresses cell proliferation of cervical cancer ( |
| Tetraspanin32 | TSPAN32, PHEMX, TSSC6 | Blood, bone marrow, heart muscle, lymphoid tissue | Significantly reduced levels in CD4 T cells of multiple sclerosis patients ( |
| Tetraspanin33 | TSPAN33, MGC50844, Penumbra | Kidney | Regulates migration of human B lymphocytes ( |
Data marked with (*) is obtained from the protein atlas database (
FIGURE 1Schematic presentation of a tetraspanin. The model depicts the conserved structural features of tetraspanins. EC1 and EC2 represent the short and large extracellular domains, respectively. Transmembrane domains TM1–TM4 and the CCG motif along with disulfide bonds between two pairs of cysteine residues in EC2 are shown. N- and C-termini as well as the intracellular loop (IL) are located in the cytosol.
FIGURE 2RNA expression levels of tetraspanins in different regions of the brain. Consensus Normalized eXpression (NX) levels shown are created by combining the data from three transcriptomics datasets (HPA, GTEx, and FANTOM5) using normalization pipeline. Each bar contains combined data of all brain regions indicated. Data used to compose the graph obtained from the Human Protein Atlas database (proteinatlas.org).
FIGURE 3Reported functions of Tspan7 in neurons. (Left) Tspan7 influences neuronal morphogenesis by regulating filopodia density and dendritic spine morphology. This is presumably mediated by interactions with integrin β1 and/or PI4K and ultimately results in remodeling of the actin cytoskeleton (Bassani et al., 2012). (Right) Tspan7 regulates synaptic function at glutamatergic synapses. Interaction of Tspan7 with PICK1 attenuates the internalization of AMPARs, which is typically mediated by the interaction of the latter with PICK1 (Perez et al., 2001). This subsequently leads to an increased availability of AMPARs at the postsynaptic membrane and thus to an enhanced excitability of the postsynaptic neuron. In this process, Tspan7 interacts with PICK1 via its C-terminus (Bassani et al., 2012). The figures are based on the illustrations of Bassani and Passafaro (2012) and Perot and Ménager (2020).
FIGURE 4Overall structure of a tetraspanin (A). Helices A–E are indicated in the EC2 domain between TM3 and TM4. Helices A, B, and E represent conserved regions, while helices C–D are variable among tetraspanins. Superposition of all previously resolved structures of tetraspanins (B). Shown is the overlay of Tspan25 (pdb model 6WVG in yellow) with Tspan28 (pdb model 5TCX in blue) and of Tspan25 (yellow) with Tspan29 (pdb model 6K4J in magenta) as well as of Tspan28 (blue) with Tspan29 (magenta).
FIGURE 5The architecture of transmembrane AMPAR regulatory proteins (TARPs) and tetraspanins (TSPANs). (A) Overall topology of TARPs (left) in comparison to tetraspanins (right). (B) Ribbon diagrams, rainbow-colored (from N-terminus in blue to C-terminus in red), representing the structures of TARPs (left) based on the structure of human TARP γ2, originally named stargazin and resolved by cryo-EM (pdb model 6DLZ, published by Twomey et al., 2018), and human Tspan25 (right), also known as CD53, resolved by crystallization and X-ray diffraction (pdb model 6WVG, published by Yang et al., 2020). Cysteine residues and disulfide bridges are presented as yellow heteroatoms and sticks, respectively. Distinct domains are labeled. Black boxes indicate the areas of TARPs and tetraspanins enlarged in panel (C). Cysteine residues forming disulfide bridges in the big loops are labeled (one-letter amino acid code with number of each residue) and presented in ball and stick style with sulfur and carbon shown in yellow and gray, respectively.
FIGURE 6Illustration of previously resolved and predicted tetraspanin structures in comparison to resolved structures of known AMPAR auxiliary subunits. Ribbon diagrams rainbow-colored (from N-terminus in blue to C-terminus in red) showing the structures of the chosen proteins from Homo sapiens, displayed with different views, one parallel to the membrane (upper) and another from the extracellular side rotated by a 90° angle (lower). In panel (A) the following structures are depicted (from left to right): Tspan25 (pdb model 6WVG), Tspan28 (pdb model 5TCX), Tspan29 (pdb model 6K4J), and Tspan6 (AlphaFold database). Panel (B) shows the structures of GSG1L (pdb model 5WEL), γ2 (pdb model 6DLZ), CNIH2 (pdb model 7OCE), and Tspan7 (AlphaFold database) from left to right.
FIGURE 7Superposition of selected tetraspanin structures with the predicted structure of Tspan6. The left side shows the superposition of the structures of Tspan6 (blue) and Tspan7 (gray) predicted by AlphaFold; both tetraspanins are known to influence glutamatergic synapses. For comparison, the overlays of the structure of Tspan6 with already known resolved structures of tetraspanins are shown on the right (from left to right): overlay of Tspan6 with Tspan25 (yellow) (PDB model 6WVG) as well as with Tspan28 (pale pink) (PDB model 5TCX), and with Tspan29 (orange) (PDB model 6K4J).
FIGURE 8Overlays of predicted and resolved structures. To obtain an impression of the accuracy and reliability of the structures predicted by AlphaFold, the corresponding pdb files of the solved structures of γ2 [(left) pdb model 6DLZ, colored in yellow] and Tspan28 [(right) pdb model 5TCX, colored in yellow] were superimposed on the respective AlphaFold predictions (colored in blue).
FIGURE 9Superimposition of AlphaFold-predicted structures of Tspan3, Tspan13, and Tspan31 with Tspan7 using ChimeraX. Aligned structures of Tspan3, Tspan13, and Tspan31 (yellow) and Tspan7 (blue). RMSD values for Tspan3/7, Tspan13/7, and Tspan31/7 are 0.9, 0.829, and 0.854 Å, respectively.
RMSD values (in Å) for human Tspan1-Tspan33 in alignment with Tspan7.
| Tspan7 aligned with | RMSD between superimposed atoms (angstroms) | Tspan7 aligned with | RMSD between superimposed atoms (angstroms) |
|
| 0.983 |
| 1.008 |
|
| 1.019 |
| 1.237 |
|
|
|
| 1.161 |
|
| 1.029 |
| 1.089 |
|
| 1.077 |
| 1.038 |
|
|
|
| 1.113 |
|
|
|
| 1.005 |
|
| 1.145 |
| 1.144 |
|
| 1.158 |
| 1.227 |
|
| 1.159 |
| 1.459 |
|
| 1.092 |
| 1.050 |
|
| 1.041 |
| 1.062 |
|
|
|
| 1.042 |
|
| 1.080 |
|
|
|
| 0.960 |
| 1.028 |
|
| 1.155 |
| 1.136 |
|
| 1.024 |
All tetraspanin structures were obtained from AlphaFold and aligned using Chimera-X. Smaller RMSD values indicate a higher similarity between the aligned protein structures. The color scheme used to highlight the values in the table refers to
FIGURE 10Putative direct interactions of tetraspanins with AMPARs at the postsynaptic membrane of a glutamatergic synapse. Shown is a GluA2 subunit in the D position in magenta, which has been proven to interact with the TARP γ8 (in rainbow colors) (right). To the left are the AlphaFold prediction models of Tspan3 and Tspan31, also colored in rainbow colors, which may also affect AMPAR function in a TARP-like manner. Red dots represent glutamate molecules. The proteins are displayed in ribbon style. The AMPAR subunit GluA2 lacks the C-terminus as well as the amino terminal domain (ATD) (PDB model: 7LEP) (Yu J. et al., 2021).